Clinical Trials Browser

Terminated × INDUSTRY × Gefitinib × Clear all

NCT02588261 2024-12-10

SOLAR

Phase 3 Terminated

530 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

NCT03599518 2023-02-08

DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Phase 1 Terminated

20 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00234468 2011-05-20

Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00234442 2009-06-30

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Phase 2 Terminated

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00237900 2009-04-23

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Phase 1/2 Terminated

Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC